Physician profile
Amy M Tyberg
NPI 1407015316
$89,954.68
in general payments reported to CMS, 2019-2025
23 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,539 · 2020: $6,669 · 2021: $22K · 2022: $21K · 2023: $31K · 2024: $662 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $27K · Food and Beverage: $3,631 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,750 · Travel and Lodging: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,634.69 |
| Food and Beverage | $3,631.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,750.00 |
| Travel and Lodging | $629.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $39,459.95 | 2019-2025 | Exalt Model D, Spyglass, Wallflex Duodenal |
| Ambu Innovation Gmbh | $17,954.69 | 2023 | |
| Endogastric Solutions, INC | $6,914.47 | 2019-2021 | |
| Ambu A/S | $6,316.80 | 2021-2022 | |
| Medtronic, INC. | $5,474.11 | 2021-2025 | Nexpowder, Prodigi, Barrx |
| Ambu INC. | $4,825.16 | 2021-2023 | |
| US Endoscopy | $3,746.45 | 2019-2020 | |
| Cook Medical LLC | $1,017.11 | 2021-2025 | Echotip, Echotip Insight, Hemospray |
| Pentax of America, INC. | $980.50 | 2021-2025 | Inspira, Pentax Medical, C2 Cryoballoon Focal Controller |
| Olympus America INC. | $494.72 | 2019-2023 | Evis Exera Lll Colonovideoscope |
| Fujifilm Healthcare Americas Corporation | $460.46 | 2022-2024 | |
| Steris Corporation | $415.97 | 2019-2023 | |
| Abbvie INC. | $375.64 | 2019-2024 | |
| Micro-Tech Endoscopy USA, INC. | $370.72 | 2022 | |
| Apollo Endosurgery US INC | $354.63 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $162.17 | 2022-2023 | Conmed Biliary |
| Creo Medical INC. | $160.61 | 2022-2023 | Speedboat |
| Covidien Lp | $142.77 | 2019 | |
| Ethicon US, LLC | $104.16 | 2022 | |
| Janssen Biotech, INC. | $97.55 | 2024 | Stelara |
| Galvanize Therapeutics, INC | $58.83 | 2023 | Aliya System |
| Lumendi LLC | $51.61 | 2019 | |
| Novo Nordisk INC | $15.60 | 2024 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Tyberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.